Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 3/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | FAAH | O00519 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | CNR1 | P21554 | 1/20 | 0.30 |
| ▸ | CNR2 | P34972 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4604007 | 0.94 | PRKCA (0.33) | PRKCAMAPTMAPK1ALDH1A1FAAH | |
| SCHEMBL4605186 | 0.89 | ALDH1A1 (0.34) | MAPTMAPK1ALDH1A1FAAHHPGD | |
| SCHEMBL4605190 | 0.89 | ALDH1A1 (0.34) | MAPTMAPK1ALDH1A1FAAHHPGD | |
| SCHEMBL4606284 | 0.89 | — | — | |
| Butyl Alcohol SCHEMBL4091034 | 0.88 | PRKCA (0.32) | PRKCAMAPTMAPK1 | |
| SCHEMBL7681610 | 0.87 | TDP1 (0.33) | LMNA | |
| SCHEMBL4651155 | 0.84 | — | — | |
| Acetamide SCHEMBL15323294 | 0.84 | — | — | |
| SCHEMBL4606281 | 0.83 | — | — | |
| Acetone SCHEMBL28329344 | 0.83 | MAPT (0.34) | PRKCAMAPTMAPK1ALDH1A1FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101299992-A | Carboxyalkyl cellulose esters for the long-acting delivery of pharmaceutically active substances | EASTMAN CHEM CO (US) | 2008-11-05 | — | — | CN | disclosed |
| EP-1942869-A2 | CARBOXYALKYL CELLULOSE ESTERS FOR SUSTAINED DELIVERY OF PHARMACEUTICALLY ACTIVE SUBSTANCES | EASTMAN CHEMICAL COMPANY (US) | 2008-07-16 | — | — | EP | disclosed |
| WO-2007056125-A2 | CARBOXYALKYL CELLULOSE ESTERS FOR SUSTAINED DELIVERY OF PHARMACEUTICALLY ACTIVE SUBSTANCES | EASTMAN CHEMICAL COMPANY (US) | 2007-05-18 | — | — | WO | disclosed |
| US-20070104787-A1 | Carboxyalkyl cellulose esters for sustained delivery of pharmaceutically active substances | EASTMAN CHEMICAL COMPANY | 2007-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070104787-A1 | Carboxyalkyl cellulose esters for sustained delivery of pharmaceutically active substances | SLC2A1, SLC2A8, SLC2A4 | PRKCA 4543/4885MAPT 3571/4885MAPK1 4413/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.